Literature DB >> 18641645

PICK1 uncoupling from mGluR7a causes absence-like seizures.

Federica Bertaso1, Chuansheng Zhang, Astrid Scheschonka, Frédéric de Bock, Pierre Fontanaud, Philippe Marin, Richard L Huganir, Heinrich Betz, Joël Bockaert, Laurent Fagni, Mireille Lerner-Natoli.   

Abstract

Absence epilepsy is a neurological disorder that causes a recurrent loss of consciousness and generalized spike-and-wave discharges on an electroencephalogram (EEG). The role of metabotropic glutamate receptors (mGluRs) and associated scaffolding proteins in absence epilepsy has been unclear to date. We investigated a possible role for these proteins in absence epilepsy, focusing on the mGluR7a receptor and its PDZ-interacting protein, protein interacting with C kinase 1 (PICK1), in rats and mice. Injection of a cell-permeant dominant-negative peptide or targeted mutation of the mGluR7a C terminus, both of which disrupt the interaction between the receptor and PDZ proteins, caused behavioral symptoms and EEG discharges that are characteristic of absence epilepsy. Inactivation of the Pick1 gene also facilitated pharmacological induction of the absence epilepsy phenotype. The cortex and thalamus, which are known to participate in absence epilepsy, were involved, but the hippocampus was not. Our results indicate that disruption of the mGluR7a-PICK1 complex is sufficient to induce absence epilepsy-like seizures in rats and mice, thus providing, to the best of our knowledge, the first animal model of metabotropic glutamate receptor-PDZ protein interaction in absence epilepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641645      PMCID: PMC2764992          DOI: 10.1038/nn.2142

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  50 in total

1.  Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site.

Authors:  H Boudin; A Doan; J Xia; R Shigemoto; R L Huganir; P Worley; A M Craig
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7.

Authors:  J Perroy; O El Far; F Bertaso; J P Pin; H Betz; J Bockaert; L Fagni
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

3.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

4.  Targeted in vivo mutations of the AMPA receptor subunit GluR2 and its interacting protein PICK1 eliminate cerebellar long-term depression.

Authors:  Jordan P Steinberg; Kogo Takamiya; Ying Shen; Jun Xia; Maria E Rubio; Sandy Yu; Wenying Jin; Gareth M Thomas; David J Linden; Richard L Huganir
Journal:  Neuron       Date:  2006-03-16       Impact factor: 17.173

5.  Cellular mechanisms of a synchronized oscillation in the thalamus.

Authors:  M von Krosigk; T Bal; D A McCormick
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

6.  (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.

Authors:  F Gasparini; V Bruno; G Battaglia; S Lukic; T Leonhardt; W Inderbitzin; D Laurie; B Sommer; M A Varney; S D Hess; E C Johnson; R Kuhn; S Urwyler; D Sauer; C Portet; M Schmutz; F Nicoletti; P J Flor
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

7.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

8.  The effects of L-AP4 and L-serine-O-phosphate on inhibition in primary somatosensory cortex of the adult rat in vivo.

Authors:  H Wan; P M Cahusac
Journal:  Neuropharmacology       Date:  1995-08       Impact factor: 5.250

9.  Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.

Authors:  Yi Zhang; Mayra Mori; Daniel L Burgess; Jeffrey L Noebels
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  PICK1 interacts with and regulates PKC phosphorylation of mGLUR7.

Authors:  K K Dev; Y Nakajima; J Kitano; S P Braithwaite; J M Henley; S Nakanishi
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

View more
  39 in total

1.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  The scaffold protein NHERF2 determines the coupling of P2Y1 nucleotide and mGluR5 glutamate receptor to different ion channels in neurons.

Authors:  Alexander K Filippov; Joseph Simon; Eric A Barnard; David A Brown
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization.

Authors:  Matthieu Sainlos; Cezar Tigaret; Christel Poujol; Nelson B Olivier; Lucie Bard; Christelle Breillat; Kevin Thiolon; Daniel Choquet; Barbara Imperiali
Journal:  Nat Chem Biol       Date:  2010-12-26       Impact factor: 15.040

4.  Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.

Authors:  Miou Zhou; Wei Xu; Guanghong Liao; Xiaoning Bi; Michel Baudry
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

Review 5.  Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

Authors:  Andreas Reiner; Joshua Levitz
Journal:  Neuron       Date:  2018-06-27       Impact factor: 17.173

Review 6.  Overview of glutamatergic neurotransmission in the nervous system.

Authors:  Mark J Niciu; Benjamin Kelmendi; Gerard Sanacora
Journal:  Pharmacol Biochem Behav       Date:  2011-08-26       Impact factor: 3.533

7.  Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.

Authors:  Dana Marafi; Tadahiro Mitani; Sedat Isikay; Jozef Hertecant; Mohammed Almannai; Kandamurugu Manickam; Rami Abou Jamra; Ayman W El-Hattab; Jaishen Rajah; Jawid M Fatih; Haowei Du; Ender Karaca; Yavuz Bayram; Jaya Punetha; Jill A Rosenfeld; Shalini N Jhangiani; Eric Boerwinkle; Zeynep C Akdemir; Serkan Erdin; Jill V Hunter; Richard A Gibbs; Davut Pehlivan; Jennifer E Posey; James R Lupski
Journal:  Ann Clin Transl Neurol       Date:  2020-04-14       Impact factor: 4.511

8.  Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.

Authors:  Nicole M Fisher; Robert W Gould; Rocco G Gogliotti; Annalise J McDonald; Hana Badivuku; Susmita Chennareddy; Aditi B Buch; Annah M Moore; Matthew T Jenkins; W Hudson Robb; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2020-04-14       Impact factor: 3.449

9.  Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD.

Authors:  Thor S Thorsen; Kenneth L Madsen; Nelson Rebola; Mette Rathje; Victor Anggono; Anders Bach; Irina S Moreira; Nicolai Stuhr-Hansen; Tino Dyhring; Dan Peters; Thijs Beuming; Richard Huganir; Harel Weinstein; Christophe Mulle; Kristian Strømgaard; Lars Christian B Rønn; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 10.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.